SJS/TEN: Study Addresses Issues in Identifying Culprit Drug

In the absence of a lab test, identifying culprit drugs in patients with SJS/TEN is difficult, and 'patients take on average six medications at the time of their reaction,' the authors of a new study write.

Related Keywords

Washington ,United States ,Boston ,Massachusetts ,George Washington University Hospital ,District Of Columbia ,Christine Ko ,Karl Saardi ,Sherriej Divito ,Yale University ,Drug Causality ,Epidermal Necrolysis ,Massachusetts General Hospital ,New Haven ,Skin And Soft Tissue Infection ,Stevens Johnson Syndrome ,Hospitals ,Patient Safety ,Allergy ,Fixed Drug Eruption ,Human Leukocyte Antigen ,La Human Leukocyte Antigen ,Allergens ,Antigens ,Drug Induced Cutaneous Eruptions ,Inpatient Care ,Medical Records ,Records ,Antibiotics ,Igecycline ,Social Determinants Of Health ,